We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.12%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$331B
AUM Growth
+$5.64B
Cap. Flow
-$2.7B
Cap. Flow %
-0.81%
Top 10 Hldgs %
12.38%
Holding
6,874
New
204
Increased
2,959
Reduced
3,018
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 9.92%
2 Financials 9.63%
3 Healthcare 8.27%
4 Consumer Discretionary 7.53%
5 Communication Services 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICCH
6301
DELISTED
ICC Holdings, Inc.
ICCH
$1K ﹤0.01%
+43
New +$710
SEEL
6302
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
ALIM
6303
DELISTED
Alimera Sciences
ALIM
$1K ﹤0.01%
27
-133
-83% -$2.85K
MRNS
6304
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
+124
New +$670
OPGN
6305
DELISTED
OpGen, Inc
OPGN
0
GENE
6306
DELISTED
Genetic Technologies Ltd.
GENE
$1K ﹤0.01%
75
YTEN
6307
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
GGE
6308
DELISTED
Green Giant Inc. Common Stock
GGE
$1K ﹤0.01%
200
-86
-30% -$283
ONCT
6309
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1K ﹤0.01%
2
+1
+100% +$613
RPT.PRD
6310
DELISTED
RPT Realty 7.25% Series D Cumulative Convertible Perpetual Preferred Shares of Beneficial Interest
RPT.PRD
$1K ﹤0.01%
18
+1
+6% +$53
ACER
6311
DELISTED
Acer Therapeutics Inc
ACER
$1K ﹤0.01%
155
GRU
6312
DELISTED
ELEMENTS Linked to the ICE BofAML Commodity Index eXtra Grains Total Return
GRU
$1K ﹤0.01%
300
GSV
6313
DELISTED
Gold Standard Ventures Corp.
GSV
$1K ﹤0.01%
425
-2,000
-82% -$3.57K
MBII
6314
DELISTED
Marrone Bio Innovations, Inc.
MBII
$1K ﹤0.01%
520
+40
+8% +$57
SPRT
6315
DELISTED
support.com, Inc.
SPRT
$1K ﹤0.01%
525
+190
+57% +$445
ZIV
6316
DELISTED
VelocityShares Daily Inverse VIX Medium Term ETN
ZIV
$1K ﹤0.01%
9
BLPH
6317
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$1K ﹤0.01%
33
WBIB
6318
DELISTED
WBI BullBear Value 2000 ETF
WBIB
$1K ﹤0.01%
+20
New +$499
WBIC
6319
DELISTED
WBI BullBear Yield 2000 ETF
WBIC
$1K ﹤0.01%
+26
New +$578
TRNX
6320
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
0
LINDW
6321
DELISTED
Lindblad Expeditions Holdings Inc. Warrant
LINDW
$1K ﹤0.01%
264
CYHHZ
6322
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
55,689
+650
+1% +$6
ESES
6323
DELISTED
Eco-Stim Energy Solutions Inc. Common Stock
ESES
$1K ﹤0.01%
+583
New +$721
DTRM
6324
DELISTED
Determine, Inc. Common Stock
DTRM
$1K ﹤0.01%
343
+76
+28% +$253
DGAZ
6325
DELISTED
VelocityShares 3x Inverse Natural Gas ETN linked to the S&P GSCI Natural Gas Index Excess Return
DGAZ
$1K ﹤0.01%
1

Similar funds

Morgan Stanley's Q2 2017 Portfolio in Review

As of Q2 2017, Morgan Stanley held 6,874 positions worth $331B, up 1.7% from $325B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley's Q2 2017 filing shows 204 new, 2,959 increased, 3,018 reduced and 165 closed positions. Its largest new stake was Altaba Inc: 6,949,032 shares worth $379M. The largest sale was iShares Russell 2000 ETF, an estimated $1.9B.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

  • Morgan Stanley's largest Q2 2017 buy was Altaba Inc: 6,949,032 shares worth $379M.
  • Morgan Stanley added most to Starbucks in Q2 2017, an estimated $500M increase.
  • Morgan Stanley's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.9B.
  • Morgan Stanley fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $539M.
  • Morgan Stanley's ten largest holdings make up 12% of its $331B portfolio in Q2 2017.
  • Morgan Stanley opened 204 new positions and closed 165 in Q2 2017.
  • Morgan Stanley's portfolio value rose 1.7% quarter-over-quarter to $331B.

Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.